Correlation Between Pliant Therapeutics and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Intellia Therapeutics, you can compare the effects of market volatilities on Pliant Therapeutics and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Intellia Therapeutics.
Diversification Opportunities for Pliant Therapeutics and Intellia Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pliant and Intellia is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Intellia Therapeutics
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Intellia Therapeutics. In addition to that, Pliant Therapeutics is 1.33 times more volatile than Intellia Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.05 per unit of volatility. If you would invest 2,766 in Intellia Therapeutics on November 28, 2024 and sell it today you would lose (1,671) from holding Intellia Therapeutics or give up 60.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.69% |
| Values | Daily Returns |
Pliant Therapeutics vs. Intellia Therapeutics
Performance |
| Timeline |
| Pliant Therapeutics |
| Intellia Therapeutics |
Pliant Therapeutics and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Intellia Therapeutics
The main advantage of trading using opposite Pliant Therapeutics and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |